P0 Stage at Radical Cystectomy for Bladder Cancer is Associated with Improved Outcome Independent of Traditional Clinical Risk Factors

European Urology

Volumn 52, Issue 3, 2007, Pages 769-776

  Kassouf, Wassim ^a   Spiess, Philippe E ^a   Brown, Gordon A ^a   Munsell, Mark F ^a   Grossman, H Barton ^a   Siefker Radtke, Arlene ^a   Dinney, Colin P N ^a   Kamat, Ashish M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bladder cancer; Cystectomy; Prognosis; pT0N0; Stage

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 34547163004     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.086     Document Type: Article

References (13)

1. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
2. Millikan R., Dinney C., Swanson D., et al. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19 (2001) 4005-4013
3. Volkmer B.G., Kuefer R., Bartsch Jr. G., et al. Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer 104 (2005) 2384-2391
4. Palapattu G.S., Shariat S.F., Karakiewicz P.I., et al. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol 175 (2006) 1645-1649 discussion 1649
5. Yiou R., Patard J.J., Benhard H., Abbou C.C., and Chopin D.K. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int 89 (2002) 374-378
6. Thrasher J.B., Frazier H.A., Robertson J.E., and Paulson D.F. Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?. J Urol 152 (1994) 393-396
7. Wijkstrom H., Norming U., Lagerkvist M., Nilsson B., Naslund I., and Wiklund P. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients. Br J Urol 81 (1998) 686-691
8. Lotan Y., Gupta A., Shariat S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533-6539
9. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 169 (2003) 943-945
10. Bochner B.H., Herr H.W., and Reuter V.E. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 166 (2001) 2295-2296
11. Shariat S.F., Palapattu G.S., Amiel G.E., et al. Impact of concomitant carcinoma in situ on clinical outcomes after radical cystectomy. J Urol 175 (2006) 403
12. Di Stasi S.M., Giannantoni A., Giurioli A., et al. Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial. Lancet Oncol 7 (2006) 43-51
13. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866